The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis

Alemtuzumab is a monoclonal antibody that binds to CD52, a protein present on the surface of mature lymphocytes, but not on the stem cells from which these lymphocytes are derived. It is currently used as an immune reconstitution therapy in patients with relapsing–remitting multiple sclerosis. Alemt...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolla, Simona, Maglione, Alessandro, De Mercanti, Stefania Federica, Clerico, Marinella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348777/
https://www.ncbi.nlm.nih.gov/pubmed/32503344
http://dx.doi.org/10.3390/cells9061396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348777/
https://www.ncbi.nlm.nih.gov/pubmed/32503344
http://dx.doi.org/10.3390/cells9061396

Ejemplares similares